Table 4.
Power Analysis
| |
Genetic model |
|
|---|---|---|
| Genetic effect | Thr/Thr vs Ala/Thr and Ala/Ala | Thr/Thr and Thr/Ala vs Ala/Ala |
| Cervical cancer in stage I, II, III, and IV (n=353) | ||
| 0.1 | 0.9599 | 0.9999 |
| 0.3 | 0.7089 | 0.9999 |
| 0.5 | 0.3706 | 0.9885 |
| 0.7 | 0.1480 | 0.6159 |
| 0.9 | 0.0592 | 0.1043 |
| Cervical cancer in stage III and IV (n=155) | ||
| 0.1 | 0.7832 | 0.9999 |
| 0.3 | 0.4732 | 0.9995 |
| 0.5 | 0.2376 | 0.9047 |
| 0.7 | 0.1074 | 0.4165 |
| 0.9 | 0.0556 | 0.0826 |
Power analysis was conducted with the following parameters: allele frequency 0.21, disease population frequency 0.018, and significance level 0.05, two-sided.